drugset / Trial / NCT04580745
Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy Volunteers
RandomizedSequentialDouble-blindOther
Summary
Phase 1a randomized, double-blind, placebo-controlled study to evaluate single and multiple ascending doses of MORF-057 in healthy subjects.
Timeline
- Start
- 2020-09-23
- Primary completion
- 2021-03-31
- Completion
- 2021-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY4268989 | Unknown | — | Oral |
Indications
No indication recorded.